Get the latest Science News and Discoveries
Targeting vulnerability in B-cell development leads to novel drug combination for leukemia - EurekAlert
Recent work by St. Jude Children’s Research Hospital scientists discovered which tumor cells resist treatment and why. By characterizing B-cells’ developmental stages, they designed and tested a drug combination to effectively treat resistant B-cell leukemia.
None
Or read this on Eureka Alert